Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by James Hardie Industries plc for the month of April 2018. The registrant is headquartered in Dublin, Ireland, and files annual reports under Form 20-F. The filing was signed on April 9, 2018.
Key Financial Metrics
The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing does not disclose material changes to financial performance or operations compared to prior periods. The primary disclosure is a Substantial Shareholding Notification dated April 6, 2018, referenced as Exhibit 99.1.
Guidance, Outlook, and Risks
The document consists primarily of a "Forward-Looking Statements" cautionary section. It identifies significant risks and uncertainties that could cause actual results to differ from projections, including:
- Asbestos Liabilities: Risks related to prior asbestos product manufacture, contributions to the Asbestos Injuries Compensation Fund (AICF), potential shortfalls in the fund, and currency exchange impacts on asbestos liabilities.
- Legal and Regulatory: Exposure to product liability, environmental, consumer class action, and other legal proceedings.
- Market Conditions: Dependence on residential and commercial construction markets, housing values, interest rates, and economic conditions in the US and Asia Pacific regions.
- Operational Risks: Supply and cost of raw materials, competition, product failures, and the integration of the Fermacell acquisition.
- Financial Risks: Ability to renew credit facilities, tax law changes, and warranty provision adequacy.
The company explicitly states it assumes no obligation to update forward-looking statements except as required by law.
Investor Verification Checklist
- Verify the details of the Substantial Shareholding Notification (Exhibit 99.1) referenced in this filing.
- Review the most recent Form 20-F or quarterly earnings release for actual financial performance metrics, as this 6-K contains none.
- Monitor updates regarding the Asbestos Injuries Compensation Fund (AICF) and associated liability estimates.
- Assess the status of the Fermacell acquisition integration and any related capital expenditure projects.
- Track changes in US and Asia Pacific housing market conditions and their impact on the company's core business.